Substituted isoindolinones
US10844039B2 · kind B2 · utility
1Cited by
6References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2019 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Nov 12, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted isoindolinones of Formula (I), methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat or ameliorate diseases, disorders, or conditions associated with protein malfunction, such as cancer, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.